Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
27.72
-0.08 (-0.29%)
At close: Sep 04, 2025, 3:59 PM
27.22
-1.80%
After-hours: Sep 04, 2025, 05:47 PM EDT
-0.29% (1D)
| Bid | 23 |
| Market Cap | 401.52M |
| Revenue (ttm) | 1.4M |
| Net Income (ttm) | -163.69M |
| EPS (ttm) | -16.57 |
| PE Ratio (ttm) | -1.67 |
| Forward PE | -2.98 |
| Analyst | n/a |
| Ask | 30 |
| Volume | 71,600 |
| Avg. Volume (20D) | 127,739.4 |
| Open | 28.09 |
| Previous Close | 27.80 |
| Day's Range | 27.01 - 28.25 |
| 52-Week Range | 10.80 - 28.49 |
| Beta | 0.31 |
About INBX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INBX
Website n/a
3 months ago
+10.89%
Inhibrx Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
10 months ago · seekingalpha.com
Inhibrx Biosciences: Reincorporated And Trying To Find A Niche With Unique PlatformINBX's two main pipeline candidates, INBRX-109 and INBRX-106, are entering critical late-stage trials with data readouts expected in mid- to late-2025. INBRX-109 targets DR5 in solid tumors, showing p...